June 2022 FDA Recall Drug by Teva Pharmaceuticals Usa Inc (D-1156-2022 - Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.)

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa Inc on June 14, 2022 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications; low out of specification (oos) results for dissolution.. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1156-2022

Reason for Recall
Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.
Initiated
06-14-2022
Reported
06-29-2022
Quantity
4941 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA Inc
Nationwide in the U.S.
Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC 0555-0808-02.

Batch or Lot Expiration Information

Lot# s: 100022971, Exp. 08/2022; 100022972, Exp. 05/2023; 100028920, Exp. 09/2023